SG11201811418YA - Oral composition - Google Patents
Oral compositionInfo
- Publication number
- SG11201811418YA SG11201811418YA SG11201811418YA SG11201811418YA SG11201811418YA SG 11201811418Y A SG11201811418Y A SG 11201811418YA SG 11201811418Y A SG11201811418Y A SG 11201811418YA SG 11201811418Y A SG11201811418Y A SG 11201811418YA SG 11201811418Y A SG11201811418Y A SG 11201811418YA
- Authority
- SG
- Singapore
- Prior art keywords
- oral composition
- mass
- content ratio
- scutellaria root
- satisfied
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
ZTCPCT 30 The present invention is characterized in that an oral composition contains scutellaria root, cinnamon bark and poria sclerotium. When a content ratio of the scutellaria root in the oral composition is defined as X A [mass%] and a content ratio of the cinnamon bark in the oral composition is defined as X B [mass%], it is preferred that the following relation is satisfied: 0.00005 ≤XB/X A≤20000. Further, when the content ratio of the scutellaria root in the oral composition is defined as X A [mass%] and a content ratio of the poria sclerotium in the oral composition is defined as X C [mass%], it is preferred that the following relation is satisfied: 0.000025≤XC/X A≤40000. This makes it possible to obtain an oral composition that contains a plurality of crude drugs and has a bad breath prevention effect which is obtained in a lower dosage than a used dosage of a single crude drug.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016128016A JP6993077B2 (en) | 2016-06-28 | 2016-06-28 | Toothpaste |
PCT/JP2016/081296 WO2018003134A1 (en) | 2016-06-28 | 2016-10-21 | Composition for use in oral cavity |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201811418YA true SG11201811418YA (en) | 2019-01-30 |
Family
ID=60786331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201811418YA SG11201811418YA (en) | 2016-06-28 | 2016-10-21 | Oral composition |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP6993077B2 (en) |
CN (1) | CN108025028A (en) |
HK (1) | HK1248131A1 (en) |
SG (1) | SG11201811418YA (en) |
TW (1) | TWI750142B (en) |
WO (1) | WO2018003134A1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3159509B2 (en) * | 1992-03-30 | 2001-04-23 | サンスター株式会社 | Protease inhibitor |
JP5675178B2 (en) | 2010-06-09 | 2015-02-25 | 大島 光宏 | Collagen degradation inhibitor |
KR20120005150A (en) * | 2010-07-08 | 2012-01-16 | 애경산업(주) | Oral cavity composition for preventing gingivitis and periodontal disease |
JP6291151B2 (en) | 2011-03-31 | 2018-03-14 | 小林製薬株式会社 | Oral composition |
CN102698122B (en) | 2012-01-10 | 2013-10-16 | 青岛华仁技术孵化器有限公司 | Traditional Chinese medicinal composition for treating paradentitis, and preparation method and administration method thereof and toothpaste |
JP2015054847A (en) | 2013-09-13 | 2015-03-23 | 一丸ファルコス株式会社 | Periodontal disease bacterial inhibitor |
CN104548141B (en) * | 2014-12-18 | 2019-09-10 | 山东省千佛山医院 | Have effects that treat gastroenteritic ulcer and the preferable gastrointestinal image agent of scribble effect |
-
2016
- 2016-06-28 JP JP2016128016A patent/JP6993077B2/en active Active
- 2016-10-21 SG SG11201811418YA patent/SG11201811418YA/en unknown
- 2016-10-21 WO PCT/JP2016/081296 patent/WO2018003134A1/en active Application Filing
- 2016-10-21 CN CN201680001526.9A patent/CN108025028A/en active Pending
- 2016-11-30 TW TW105139492A patent/TWI750142B/en active
-
2018
- 2018-06-14 HK HK18107721.1A patent/HK1248131A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018003134A1 (en) | 2018-01-04 |
JP6993077B2 (en) | 2022-01-13 |
JP2018002614A (en) | 2018-01-11 |
HK1248131A1 (en) | 2018-10-12 |
TW201800087A (en) | 2018-01-01 |
CN108025028A (en) | 2018-05-11 |
TWI750142B (en) | 2021-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015160842A8 (en) | Methods and formulations of capsaicinoids and capsinoids | |
WO2018234568A3 (en) | Hydroxynorketamine for the use in the treatment of depression | |
MX2016011700A (en) | Surface-reacted calcium carbonate for desensitizing teeth. | |
PH12017502325A1 (en) | Orodispersible dosage unit containing an estetrol component | |
WO2017136617A8 (en) | Deuterated domperidone compositions and methods for therapy of disorders | |
WO2016190682A3 (en) | Composition for preventing and treating muscle diseases or improving muscular function, containing morusin, kuwanon g, or mori cortex radicis | |
MX2017002584A (en) | Composition and medicinal product for reducing body weight and body fat, and use of said product. | |
EA201791531A1 (en) | NATURAL SPREADER | |
PH12019502241A1 (en) | Berberine alkaloids in the prevention and/or treatments of intestinal disease | |
MX2017009929A (en) | Compositions and methods for improved muscle metabolism. | |
WO2018088813A3 (en) | Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredient | |
GB2519432A9 (en) | Fungicidal mixture | |
MY190399A (en) | A composition comprising cistanche and ginkgo extracts, the composition useful for improving memory of a subject | |
BR112019001207A2 (en) | vaginal composition comprising a combination of estrogen and vitamin d | |
SG11201811418YA (en) | Oral composition | |
PH12016501991A1 (en) | Flavouring composition | |
MX2021005910A (en) | High concentration protein formulation. | |
Lladó | Sedation for endoscopy in 2016-Is endoscopist-guided sedation safe in complex situations? | |
WO2014145289A3 (en) | Compositions derived from sweet potato greens and methods of preparation and use | |
WO2016114621A3 (en) | Composition for prevention or treatment of metabolic bone diseases comprising combined extract of schisandra chinesis, eucommiae cortex and lycium chinense as active ingredient | |
CA3153252A1 (en) | Composition for preventing or treating neurodegenerative diseases containing mixed herbal extract of genkwae flos, clematidis radix, and gastrodiae rhizoma | |
WO2016182399A3 (en) | Pharmaceutical composition for preventing and treating chronic obstructive lung disease containing, as active ingredient, magnoliae flos extract, fraction, or active fraction thereof | |
WO2019077629A3 (en) | Compositions for improving lean body mass, brown adipose tissue and for inhibiting advanced glycation end products | |
PL422460A1 (en) | Herbal composition that facilitates gluten digestion | |
UA106935U (en) | Composition for treatment and prevention of diseases of prostate in a form of suppository |